| uPA系统与肿瘤的研究进展 |
| |
| 引用本文： | 潘其壮. uPA系统与肿瘤的研究进展[J]. 医学综述, 2010, 16(14): 2140-2143 |
| |
| 作者姓名： | 潘其壮 |
| |
| 作者单位： | 桂林医学院附属医院泌尿外科,广西,桂林,541001 |
| |
| 摘 要： | 尿激酶型纤溶酶原激活物(uPA)简称尿激酶,它是纤溶酶原的主要激活物之一。近年来发现uPA系统成分在肿瘤组织以及循环血中的高表达与多种肿瘤的病理特点、预后相关。已成为肿瘤标志物的研究热点之一。现针对uPA系统成分的功能,在目前研究较多的肿瘤中的作用及其测定的研究进展予以综述。
|
| 关 键 词： | 尿激酶型纤溶酶原激活物 尿激酶 受体 肿瘤 |
Research Progress of uPA System and Tumor |
| |
| PAN Qi-zhuang. Research Progress of uPA System and Tumor[J]. Medical Recapitulate, 2010, 16(14): 2140-2143 |
| |
| Authors: | PAN Qi-zhuang |
| |
| Abstract: | Urokinase plasminogen activator is called uPA for short,as one of the main activators of fibrinolytic enzymes.In recent years,it has been found that the high expression of uPA system in tumor tissue and circulation is related with the pathological characteristics and the prognosis of multiple tumors.It has become one of the hotspots of in the tumor marker study.Now in this review,we discussed the development in the function of urokinase system component and measures. |
| |
| Keywords: | Urokinase plasminogen activator Urokinase Receptors Tumor |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
